# Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

> **NCT00634972** · PHASE4 · TERMINATED · sponsor: **University of South Alabama** · enrollment: 83 (actual)

## Conditions studied

- Retinopathy of Prematurity
- Retinal Detachment
- Blindness

## Interventions

- **DRUG:** ACULAR
- **DRUG:** REFRESH TEARS
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00634972
- **Lead sponsor:** University of South Alabama
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** The study could not be completed as the company producing this product interrupted their supply of this medication
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00634972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00634972, "Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00634972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*